140 related articles for article (PubMed ID: 35236268)
1. Polymorphism Rs2421943 of the Insulin-Degrading Enzyme Gene and the Risk of Late-Onset Alzheimer's Disease.
Šerý O; Zeman T; Hálová A; Janout V; Janoutová J; Lochman J; Balcar VJ
Curr Alzheimer Res; 2022; 19(3):236-245. PubMed ID: 35236268
[TBL] [Abstract][Full Text] [Related]
2. Association between polymorphism rs2421943 of the insulin-degrading enzyme and schizophrenia: Preliminary report.
Ambrozová L; Zeman T; Janout V; Janoutová J; Lochman J; Šerý O
J Clin Lab Anal; 2023 Jul; 37(13-14):e24949. PubMed ID: 37515308
[TBL] [Abstract][Full Text] [Related]
3. Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis.
Qiu WQ; Folstein MF
Neurobiol Aging; 2006 Feb; 27(2):190-8. PubMed ID: 16399206
[TBL] [Abstract][Full Text] [Related]
4. Insulin-degrading enzyme: Roles and pathways in ameliorating cognitive impairment associated with Alzheimer's disease and diabetes.
Tian Y; Jing G; Zhang M
Ageing Res Rev; 2023 Sep; 90():101999. PubMed ID: 37414154
[TBL] [Abstract][Full Text] [Related]
5. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.
Farris W; Mansourian S; Chang Y; Lindsley L; Eckman EA; Frosch MP; Eckman CB; Tanzi RE; Selkoe DJ; Guenette S
Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4162-7. PubMed ID: 12634421
[TBL] [Abstract][Full Text] [Related]
6. Insulin-degrading enzyme, apolipoprotein E, and Alzheimer's disease.
Edland SD
J Mol Neurosci; 2004; 23(3):213-7. PubMed ID: 15181249
[TBL] [Abstract][Full Text] [Related]
7. New Insights on the Regulation of the Insulin-Degrading Enzyme: Role of microRNAs and RBPs.
Martín-Martín Y; Pérez-García A; Torrecilla-Parra M; Fernández-de Frutos M; Pardo-Marqués V; Casarejos MJ; Busto R; Ramírez CM
Cells; 2022 Aug; 11(16):. PubMed ID: 36010613
[TBL] [Abstract][Full Text] [Related]
8. Disorder-specific effects of polymorphisms at opposing ends of the Insulin Degrading Enzyme gene.
Bartl J; Scholz CJ; Hinterberger M; Jungwirth S; Wichart I; Rainer MK; Kneitz S; Danielczyk W; Tragl KH; Fischer P; Riederer P; Grünblatt E
BMC Med Genet; 2011 Nov; 12():151. PubMed ID: 22107728
[TBL] [Abstract][Full Text] [Related]
9. Identification and functional characterization of a putative IDE, C28F5.4 (ceIDE-1), in Caenorhabditis elegans: Implications for Alzheimer's disease.
Haque R; Nazir A
Biochim Biophys Acta; 2016 Nov; 1860(11 Pt A):2454-2462. PubMed ID: 27443962
[TBL] [Abstract][Full Text] [Related]
10. Insulin-degrading enzyme is genetically associated with Alzheimer's disease in the Finnish population.
Vepsäläinen S; Parkinson M; Helisalmi S; Mannermaa A; Soininen H; Tanzi RE; Bertram L; Hiltunen M
J Med Genet; 2007 Sep; 44(9):606-8. PubMed ID: 17496198
[TBL] [Abstract][Full Text] [Related]
11. Insulin degrading enzyme contributes to the pathology in a mixed model of Type 2 diabetes and Alzheimer's disease: possible mechanisms of IDE in T2D and AD.
Li H; Wu J; Zhu L; Sha L; Yang S; Wei J; Ji L; Tang X; Mao K; Cao L; Wei N; Xie W; Yang Z
Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29222348
[TBL] [Abstract][Full Text] [Related]
12. Common Pesticide, Dichlorodiphenyltrichloroethane (DDT), Increases Amyloid-β Levels by Impairing the Function of ABCA1 and IDE: Implication for Alzheimer's Disease.
Li G; Kim C; Kim J; Yoon H; Zhou H; Kim J
J Alzheimers Dis; 2015; 46(1):109-22. PubMed ID: 25720399
[TBL] [Abstract][Full Text] [Related]
13. Toward Allosterically Increased Catalytic Activity of Insulin-Degrading Enzyme against Amyloid Peptides.
Kurochkin IV; Guarnera E; Wong JH; Eisenhaber F; Berezovsky IN
Biochemistry; 2017 Jan; 56(1):228-239. PubMed ID: 27982586
[TBL] [Abstract][Full Text] [Related]
14. Reduced amyloid-β degradation in early Alzheimer's disease but not in the APPswePS1dE9 and 3xTg-AD mouse models.
Stargardt A; Gillis J; Kamphuis W; Wiemhoefer A; Kooijman L; Raspe M; Benckhuijsen W; Drijfhout JW; Hol EM; Reits E
Aging Cell; 2013 Jun; 12(3):499-507. PubMed ID: 23534431
[TBL] [Abstract][Full Text] [Related]
15. Effects of ageing and experimental diabetes on insulin-degrading enzyme expression in male rat tissues.
Kochkina EG; Plesneva SA; Vasilev DS; Zhuravin IA; Turner AJ; Nalivaeva NN
Biogerontology; 2015 Aug; 16(4):473-84. PubMed ID: 25792373
[TBL] [Abstract][Full Text] [Related]
16. Characterization of insulin degrading enzyme and other amyloid-β degrading proteases in human serum: a role in Alzheimer's disease?
Liu Z; Zhu H; Fang GG; Walsh K; Mwamburi M; Wolozin B; Abdul-Hay SO; Ikezu T; Leissring MA; Qiu WQ
J Alzheimers Dis; 2012; 29(2):329-40. PubMed ID: 22232014
[TBL] [Abstract][Full Text] [Related]
17. Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele.
Cook DG; Leverenz JB; McMillan PJ; Kulstad JJ; Ericksen S; Roth RA; Schellenberg GD; Jin LW; Kovacina KS; Craft S
Am J Pathol; 2003 Jan; 162(1):313-9. PubMed ID: 12507914
[TBL] [Abstract][Full Text] [Related]
18. Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid beta-protein.
Farris W; Mansourian S; Leissring MA; Eckman EA; Bertram L; Eckman CB; Tanzi RE; Selkoe DJ
Am J Pathol; 2004 Apr; 164(4):1425-34. PubMed ID: 15039230
[TBL] [Abstract][Full Text] [Related]
19. Insulin-degrading enzyme and Alzheimer disease: a genetic association study in the Han Chinese.
Bian L; Yang JD; Guo TW; Sun Y; Duan SW; Chen WY; Pan YX; Feng GY; He L
Neurology; 2004 Jul; 63(2):241-5. PubMed ID: 15277615
[TBL] [Abstract][Full Text] [Related]
20. Profile of Pathogenic Proteins and MicroRNAs in Plasma-derived Extracellular Vesicles in Alzheimer's Disease: A Pilot Study.
Li F; Xie XY; Sui XF; Wang P; Chen Z; Zhang JB
Neuroscience; 2020 Apr; 432():240-246. PubMed ID: 32135232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
